Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people? Willicombe M, Scanlon M, Loud F, Lightstone L, et al. BMJ 2022;377:o966.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Willicombe M, Scanlon M, Loud F, Lightstone L, et al. Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people? BMJ 2022;377:o966.
PMID: 35414604